“I had one (blood clot) close to my heart and I had one in my lung that had blocked off an entire section and was turning gangrenous,” Ms. Saul said in comments published in The West Australian (8/20/13). Saul reports that she had been taking Yaz for two years and had not experienced any outward Yaz side effects. However, she did have health issues nonetheless, and doctors told her that her use of Yaz “greatly exacerbated” her health issues.
Yasmin birth control and its sister product Yaz were introduced by Bayer HealthCare Pharmaceuticals as a new-age oral contraceptive based on drospirenone, a synthetic hormone. The duo was promoted as featuring many benefits to younger women, including minimized weight gain and help with acne. Women the world over embraced the pills. While Bayer admitted that users of Yasmin and Yaz were at a risk for Yasmin blood clots, the risk for blood clots was no greater than that for other birth control pills.
However, that does not appear to be the case, as various studies have suggested a higher risk for blood clots associated with drospirenone. Thousands of Yaz lawsuits and similar actions involving Yasmin have been launched against Bayer.
READ MORE YASMIN BIRTH CONTROL LEGAL NEWS
The two women have joined a potential class-action lawsuit related to their Yaz side effects. Yaz has been on the market since 2008, and Saul switched to Yaz as soon as it appeared. Yasmin arrived on the scene in Australia first, in 2002.
Two studies published in the BMJ in 2011 found that women who used contraceptive pills like Yasmin were twice as likely to develop blood clots, including Yasmin and DVT.
Yasmin gallbladder problems have also been alleged.